CREDIT SUISSE AG/ - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 75 filers reported holding RELMADA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3
-100.0%
1
-100.0%
0.00%
-100.0%
Q3 2022$617,000
+81.5%
16,680
-6.9%
0.00%
Q2 2022$340,000
-28.9%
17,922
+1.3%
0.00%
Q1 2022$478,000
+94.3%
17,696
+62.2%
0.00%
Q4 2021$246,000
+6.5%
10,907
+51.0%
0.00%
Q2 2021$231,000
-9.1%
7,223
+0.3%
0.00%
Q1 2021$254,000
-33.7%
7,204
-39.8%
0.00%
Q4 2020$383,000
+71.0%
11,975
+100.8%
0.00%
Q3 2020$224,000
-36.9%
5,963
-25.0%
0.00%
Q2 2020$355,0007,9470.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders